Introduction
Tuberculosis (TB) is a global public health problem and remains a major cause of death worldwide, especially in Asia and Africa. One-third of the world's population is infected with Mycobacterium tuberculosis. However, only approximately 5e10% of those infected develop the active disease in their lifetime. 1 TB is a highly complex disease, and the reason why some infected individuals develop active disease, while others do not is not yet understood completely. Although pathogens and environmental factors are supposed to contribute to TB, increasing evidence suggests that host genetic factors play a significant role in TB susceptibility.
2e4 Genetic studies on TB have shown that the genetic polymorphisms, potentially involved in the immune response to TB, may lead to susceptibility to or protection from TB. The DC-SIGN gene is located on chromosome 19p13.2e3. DC-SIGN might be a key part of the host immunity to TB and one of the candidate genes for susceptibility to TB. DC-SIGN is mainly expressed on dendritic cells (DCs) and alveolar macrophages. DCs are professional antigen presenting cells playing a crucial role in connecting innate and adaptive immunity.
5 DC-SIGN acts as a major receptor for M. tuberculosis in human DCs and plays an important first-line role in host defense against pathogens, by internalization and presentation of the bacterium. 6 In mature DCs, DC-SIGN promotes the activation and proliferation of resting T cells and increases primary immune responses. 7 Although, possible genetic associations between TB and e366 A/G polymorphism of CD209 have been investigated in previous studies, the findings are contradictory.
8e12 Genetic risk factors for TB may differ among different populations. Subsequently, previously reported genetic associations in other populations should be investigated repeatedly to determine the associations of the genetic risk in each population. Although, the associations between CD209 e336A/G polymorphism and the risk of TB have been studied, the findings are controversial. 9,10,13e15 To the best of our knowledge, there is no report regarding the impact of this polymorphism on susceptibility to TB in Iranian population. Therefore, the present study was conducted to find out the possible association between e366 A/G polymorphism of CD209 and the risk of/protection from pulmonary tuberculosis (PTB) in a sample of Iranian population.
Materials and methods
This caseecontrol study was conducted in 156 patients with PTB and 154 healthy individuals, in the Research Center for Infectious Diseases and Tropical Medicine, Bou-Ali Hospital, Zahedan, Iran. The local ethics committee of the Zahedan University of Medical Sciences approved the project, and written informed consent was obtained from all participants. All control individuals were from the same geographical origin and living in the same region as the patients with PTB (Zahedan, southeast Iran).
The diagnosis of PTB was based on clinical symptoms, radiological evidence, and bacteriological investigations such as sputum acid-fast bacillus smear positivity, culture, and response to anti-TB chemotherapy, as described previously. 16, 17 Whole-blood samples were collected in sodiumethylenediaminetetraacetic acid (Na-EDTA) tubes from all participants and genomic DNA was extracted as described previously. 18 The CD209 genomic sequence (NT_077812.2) was obtained from the National Center for Biotechnology Information (NCBI). The rs4804803 polymorphism was searched, and primers for tetra-primer amplification refractory mutation system-polymerase chain reaction (T-ARMS-PCR) were designed (Table 1 ). This method is a rapid and simple technique for detection of single-nucleotide polymorphism.
19e21 In T-ARMS-PCR method, four primers (two external primers and two allele-specific internal primers) were used. Product sizes were 197 bp for the G allele, 292 bp for the A allele, and 442 bp for the control band.
PCR was performed using a PCR premix (AccuPower PCR PreMix, Bioneer, Daejeon, Korea). Into a 0.2-mL PCR tube containing the AccuPower PCR PreMix, 1 mL template DNA (w100 ng/mL), 1 mL of each primer (10 mM), and 15 mL DNase-free water were added. PCR was performed under the following conditions: 95 C for 5 minutes; 95 C for 30 seconds, 61 C for 25 seconds, 72 C for 30 seconds, 30 cycles; and 72 C for 10 minutes. The PCR products were electrophoresed on 2% agarose gels and photographed (Fig. 1) . We regenotyped random samples to verify the accuracy of genotyping. No genotyping mistake was found.
Statistical analysis
The statistical analysis of the data was performed using the SPSS 18.0 software (SSPS Inc., Chicago, IL, USA). Demographics and biochemical parameters between the 
Discussion
In the present study, we examined the impact of rs4804803 DC-SIGN polymorphism on the risk of PTB in a sample of Iranian population. Our findings showed that GG genotype as well as the G allele increased the risk of PTB in our population. In agreement with our finding, Barreiro et al 8 reported that e336 A decreased the risk of developing TB in a cohort of individuals of South African colored origin. By contrast, Vannberg et al 10 observed that e336 G exhibited significant protection against pulmonary TB in sub-Saharan Africa. In contrast to our finding, Olesen et al, 11 in the north African city of Tunis, and Ben-Ali et al, 9 in the west African city of Guinea-Bissau, found no association between e336 A/G polymorphism and TB. Furthermore, Zheng et al 12 have found that e336A/G (rs4804803) polymorphism of DC-SIGN is not associated with susceptibility to TB in Chinese population. Kobayashi et al 22 have found no association between this variant and the risk of TB in Indonesian population. Gomez et al 23 reported that e336 A/G variant did not increase the risk of TB in non-African individuals from northwestern Colombia,.
During preparation of this manuscript, two metaanalyses were published. A meta-analysis of 10 studies (2598 TB patients and 2614 control individuals) performed by Miao et al 13 found no association between CD209 e336A/G polymorphism and the risk of TB (OR Z 1.02, 95% CI Z 0.90e1.15, for G vs. A allele). Another meta-analysis was carried out by Chang et al., 15 based on the data extracted from 14 studies (3610 cases and 3539 controls). They observed that CD209 promoter e336A/G Figure 1 . Electrophoresis pattern of T-ARMS-PCR for detection of e366 A/G (rs4804803) polymorphism of DC-SIGN. Lane 1 Z GG; Lane 2 Z AG; Lane 3 Z AA; M Z DNA marker; T-ARMS-PCR Z tetra-amplification refractory mutation systempolymerase chain reaction. Analyzing the association between CD209 e336A/G polymorphism and the risk of TB in different ethnicities, they found that the GG genotype increased the risk of TB in Asians. 15 Our result is in agreement with this finding. Ogarkov et al 24 have found a correlation between infection with Beijing genotype and human CD209 e336A/G polymorphism. The frequency of e336G allele was significantly lower among the patients affected with Beijing strains than among those infected with non-Beijing strains. In another study, they investigated a possible combination of M. tuberculosis lineage and human host allele/genotype correlating with adverse outcome of the disease.
14 They proposed that although carriers of the CD209 e336A allele are more sensitive to infection with a Beijing strain, a combination of human CD209 e336G allele and M. tuberculosis Beijing genotype leads more frequently to lethal outcomes in pulmonary TB male patients in Caucasian population. 14 It has been proposed that e336A/G variant in the CD209 (DC-SIGN) gene promoter region regulates promoter activity by affecting a Sp1-like binding site. 12 Although the data indicated a discrepancy, both studies suggested an important role of e366 A/G polymorphism of CD209 in the development of TB. There is no clear explanation for the different findings in different studies. Ethnic, genetic, and/or environmental factors may interact in various ways to either decrease or increase the susceptibility to TB in different regions. 25 This is the first report regarding the association between e366 A/G polymorphism of CD209 and PTB in Iranian population.
In conclusion, our results indicate that CD209 rs4804803 polymorphism increased the risk of PTB in a sample of Iranian population. Larger studies are needed to validate our findings.
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